Use of the subcutaneous basal-bolus regimen with once-daily basal insulin and rapid-acting insulin injections before meals has improved hospital hyperglycaemias and has resulted in reduced risk of complications during the hospitalization [9,10,20]. The gene discussed is INS; the disease is Hyperglycemia.